论文部分内容阅读
目的:研究中西医结合治疗乙肝肝硬化顽固性腹水的临床疗效。方法:将80例乙肝肝硬化顽固性腹水患者随机分为对照组39例和治疗组41例,对照组患者采用单纯西医疗法,治疗组患者在此基础上辅以中医治疗,比较两组患者的临床疗效。结果:经过治疗,治疗组患者临床总有效率为92.7%,显著高于对照组的56.4%,组间比较差异具有统计学意义(P<0.05)。结论:中西医结合治疗乙肝肝硬化顽固性腹水临床疗效显著,可有效消除腹部肿胀,值得临床推广应用。
Objective: To study the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of refractory ascites due to hepatitis B cirrhosis. Methods: Eighty patients with cirrhosis of liver cirrhosis and refractory ascites were randomly divided into control group (n = 39) and treatment group (n = 41). Patients in the control group were treated with western medicine alone. Patients in the treatment group were supplemented with Chinese medicine on the basis of this study. Clinical efficacy. Results: After treatment, the total clinical effective rate of the treatment group was 92.7%, significantly higher than that of the control group (56.4%). There was significant difference between the two groups (P <0.05). Conclusion: Integrative treatment of hepatitis B cirrhosis refractory ascites clinical curative effect is significant, can effectively eliminate abdominal swelling, it is worth clinical application.